Key figures

sanofi-pasteur
• About 9,000 employees
  worldwide,
  of which about 1,500
  working in R&D,
• 3 research and
  development sites:
  France, the United States
  and Canada,
• 2005 pro forma net sales:
  2.06 billion euros,
  More than 1 billion
  vaccine doses
  were sold in 2005,
  protecting over 500
  million people
• The widest range
  of vaccines against
  20 bacterial and viral
  diseases,
• Sanofi pasteur MSD,
  a joint venture
  with Merck&Co.,
  markets sanofi pasteur
  vaccines in
  19 European countries.

Sanofi-aventis, one of the world's leading pharmaceutical companies in the service of health worldwide

• Number 1 in Europe
• Present in 100 countries
• Nearly 100,000 employees
• Pro forma net sales: 28 billion euros in 2007

Research the world over

• Over 18,000 research staff working on all research and development processes
• Over 25 research and development centers on 3 continents

… focused on performance and innovation…

• 3rd largest R&D budget in the pharmaceutical industry: over 4.5 billion euros in 2007
• A rich, innovative and balanced R&D portfolio: 113 products under development, 47 of which are in advanced stages of clinical investigation (phases IIb and III), and 59 in early stages (preclinical phase and phase I)

… in these major therapeutic areas

• Cardiovascular disease
• Thrombosis
• Metabolic disorders
• Oncology
• Disorders of the central nervous system
• Internal medicine
• Vaccines